NCT06855628CompletedPhase 2
Assessment of Novel Metabolic Imaging Modalities as A Predictor Of Therapeutic EfficacyiIn Glioblastoma (GBM)
Assessment Of A Novel Metabolic Imaging Modalities As A Predictor Of Therapeutic Efficacy In Glioblastoma (GBM)
Source: ClinicalTrials.gov · Last updated 30 Sept 2026
Brief summary (registry, in English)
The goal of this study is to evaluate the prognostic capacity of DMI in a trial assessing the efficacy of adding BPM31510, a lipid nano dispersion of CoQ10 to standard treatment of Glioblastoma (GBM).
- Status (registry)
- Completed
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 2 (actual)
- First submitted
- 26 Feb 2025
- Start date
- 30 Jan 2025
- Primary completion date
- 13 Jul 2026
- Lead sponsor
- Stanford University
- Diseases
- Glioblastoma
- NCT number
- NCT06855628
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 2
- From 30 Jan 2025 to the primary completion date, 13 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Allergy to MRI contrasts
Other
- Refuse to have an IV
- Diabetic patients who are taking insulin
Who the study is looking for
- Any participant that consents to entry into the Phase II BPM31510 parent study (BPM31510IV-11)
- Women of childbearing potential must have a negative pregnancy test
- Ability to understand and the willingness to provide written informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Stanford University Coordinator of this site? Confirm its status | Palo Alto | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.